The Use of MR-Guided Radiation Therapy for Liver Cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38105091.
- Also identified by DOI 10.1016/j.semradonc.2023.10.006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The role of radiotherapy in the management of primary and metastatic liver malignancies has expanded in recent years due to advances such as IGRT and SBRT. MRI-guided radiotherapy (MRgRT) has arisen as an excellent option for the management of hepatocellular carcinoma, cholangiocarcinoma, and liver metastases due to the ability to combine improved hepatic imaging with conformal treatment planning paradigms like adaptive radiotherapy and advanced motion management techniques. Herein we review the data for MRgRT for liver malignancies, as well as describe workflow and technical considerations for the 2 commercially available MRgRT delivery platforms.
Medical subject headings
- Radiotherapy, Image-Guided
- Liver Neoplasms